Summary

North America (NAFTA) Pet Healthcare Market Summary, Competitive Analysis and Forecast, 2017-2026

Summary

The NAFTA Pet Healthcare industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The pet healthcare industry within the NAFTA countries had a total market value of $12,310.6 million in 2021.The Mexico was the fastest growing country, with a CAGR of 4.2% over the 2017-21 period.
- Within the pet healthcare industry, the US is the leading country among the NAFTA bloc, with market revenues of $11,531.3 million in 2021. This was followed by Canada and Mexico, with a value of $521.8 and $257.5 million, respectively.
- The US is expected to lead the pet healthcare industry in the NAFTA bloc, with a value of $13,960.6 million in 2026, followed by Canada and Mexico with expected values of $615.6 and $330.8 million, respectively.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the NAFTA pet healthcare market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the NAFTA pet healthcare market
- Leading company profiles reveal details of key pet healthcare market players’ NAFTA operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the NAFTA pet healthcare market with five year forecasts by both value and volume
- Compares data from the US, Canada and Mexico, alongside individual chapters on each country

Reasons to Buy

- What was the size of the NAFTA pet healthcare market by value in 2021?
- What will be the size of the NAFTA pet healthcare market in 2026?
- What factors are affecting the strength of competition in the NAFTA pet healthcare market?
- How has the market performed over the last five years?
- Who are the top competitors in the NAFTA pet healthcare market?

ページTOPに戻る

Table of Contents

Table of Contents
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 NAFTA Pet Healthcare
2.1. Industry Outlook
3 Pet Healthcare in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pet Healthcare in Mexico
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Pet Healthcare in The United States
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Company Profiles
9.1. Rolf C. Hagen Inc
9.2. Nestle SA
9.3. Boehringer Ingelheim GmbH
9.4. The J.M. Smucker Co
9.5. Zoetis Inc
9.6. Bayernland eG
9.7. Neogen Corp
9.8. Eli Lilly and Company
10 Appendix
10.1. Methodology
10.2. About MarketLine